View Item 

Show simple item record

Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms

dc.contributor.authorScheel, Adamen_US
dc.contributor.authorLin, Giant C.en_US
dc.contributor.authorMcHugh, Jonathan B.en_US
dc.contributor.authorKomarck, Christine M.en_US
dc.contributor.authorWalline, Heather M.en_US
dc.contributor.authorPrince, Mark E.en_US
dc.contributor.authorZacharek, Mark A.en_US
dc.contributor.authorCarey, Thomas E.en_US
dc.date.accessioned2015-08-05T16:47:32Z
dc.date.available2016-09-06T15:43:59Zen
dc.date.issued2015-08en_US
dc.identifier.citationScheel, Adam; Lin, Giant C.; McHugh, Jonathan B.; Komarck, Christine M.; Walline, Heather M.; Prince, Mark E.; Zacharek, Mark A.; Carey, Thomas E. (2015). "Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms." International Forum of Allergy & Rhinology 5(8): 701-707.en_US
dc.identifier.issn2042-6976en_US
dc.identifier.issn2042-6984en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/112266
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherMosby Elsevieren_US
dc.subject.otherEGFRen_US
dc.subject.otherp16en_US
dc.subject.otherCyclin D1en_US
dc.subject.otherp53en_US
dc.subject.otherDIPS‐PCRen_US
dc.subject.otherintegrationen_US
dc.subject.otherinverted papillomaen_US
dc.subject.otherHPVen_US
dc.titleHuman papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanismsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelAllergy and Clinical Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/112266/1/alr21524.pdf
dc.identifier.doi10.1002/alr.21524en_US
dc.identifier.sourceInternational Forum of Allergy & Rhinologyen_US
dc.identifier.citedreferenceLin GC, Zacharek MA, Akkina S, et al. Inverted papilloma: prognostic factors with implications for resection margins. J Neurol Surg B. 2013; 74 ( S 01 ): A061.en_US
dc.identifier.citedreferenceLin GC, Scheel A, Akkina S, et al. Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papilloma. Int Forum Allergy Rhinol. 2013; 3: 885 – 889.en_US
dc.identifier.citedreferenceAkerman GS, Tolleson WH, Brown KL, et al. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res. 2001; 61: 3837 – 3843.en_US
dc.identifier.citedreferenceJohnston D, Hall H, DiLorenzo TP, Steinberg BM. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus‐infected laryngeal papillomas. Cancer Res. 1999; 59: 968 – 974.en_US
dc.identifier.citedreferenceWilliams SMG, Disbrow GL, Schlegel R, Lee D, Threadgill DW, Lambert PF. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high‐risk human papillomavirus oncogene. Cancer Res. 2005; 65: 6534 – 6542.en_US
dc.identifier.citedreferenceKatori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol. 2005; 31: 905 – 911.en_US
dc.identifier.citedreferenceChao J‐C, Fang S‐Y. Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity. Eur Arch Otorhinolaryngol. 2008; 265: 917 – 922.en_US
dc.identifier.citedreferenceReimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007; 120: 1731 – 1738.en_US
dc.identifier.citedreferenceSinghi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience. Cancer. 2010; 116: 2166 – 2173.en_US
dc.identifier.citedreferenceAltavilla G, Staffieri A, Busatto G, Canesso A, Giacomelli L, Marioni G. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki‐67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol. 2009; 129: 1242 – 1249.en_US
dc.identifier.citedreferenceAkagi K, Li J, Broutian TR, et al. Genome‐wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014; 24: 185 – 199.en_US
dc.identifier.citedreferenceHuebbers CU, Preuss SF, Kolligs J, et al. Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile‐onset laryngeal papillomatosis. PloS One. 2013; 8: e57207.en_US
dc.identifier.citedreferenceMcKay SP, Grégoire L, Lonardo F, Reidy P, Mathog RH, Lancaster WD. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005; 115: 1428 – 1431.en_US
dc.identifier.citedreferenceGravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000; 38: 357 – 361.en_US
dc.identifier.citedreferenceWalline HM, Komarck C, McHugh JB, et al. High‐risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. JAMA Otolaryngol Head Neck Surg. 2013; 139: 1320 – 1327.en_US
dc.identifier.citedreferenceLi H, Yang Y, Zhang R, et al. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. J Clin Virol. 2013; 56: 342 – 347.en_US
dc.identifier.citedreferenceLuft F, Klaes R, Nees M, et al. Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells. Int J Cancer. 2001; 92: 9 – 17.en_US
dc.identifier.citedreferenceMatovina M, Sabol I, Grubišić G, Gašperov NM, Grce M. Identification of human papillomavirus type 16 integration sites in high‐grade precancerous cervical lesions. Gynecol Oncol. 2009; 113: 120 – 127.en_US
dc.identifier.citedreferenceAnari S, Carrie S. Sinonasal inverted papilloma: narrative review. J Laryngol Otol. 2010; 124: 705 – 715.en_US
dc.identifier.citedreferenceCastle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002; 68: 417 – 423.en_US
dc.identifier.citedreferenceSmits HL, Bollen LJ, Tjong AHSP, et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol. 1995; 33: 2631 – 2636.en_US
dc.identifier.citedreferenceQu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol. 1997; 35: 1304 – 1310.en_US
dc.identifier.citedreferenceKlimov E, Vinokourova S, Moisjak E, et al. Human papilloma viruses and cervical tumours: mapping of integration sites and analysis of adjacent cellular sequences. BMC Cancer. 2002; 2: 24.en_US
dc.identifier.citedreferenceReuter S, Bartelmann M, Vogt M, et al. APM‐1, a novel human gene, identified by aberrant co‐transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ‐zinc finger protein with growth inhibitory activity. EMBO J. 1998; 17: 215 – 222.en_US
dc.identifier.citedreferenceFerber MJ, Thorland EC, Brink AA, et al. Preferential integration of human papillomavirus type 18 near the c‐myc locus in cervical carcinoma. Oncogene. 2003; 22: 7233 – 7242.en_US
dc.identifier.citedreferenceBonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5‐year survival data from a phase 3 randomised trial, and relation between cetuximab‐induced rash and survival. Lancet Oncol. 2010; 11: 21 – 28.en_US
dc.identifier.citedreferenceChaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294 ‐ 4301.en_US
dc.identifier.citedreferenceMarur S, D'Souza G, Westra WH, Forastiere AA. HPV‐associated head and neck cancer: a virus‐related cancer epidemic. Lancet Oncol. 2010; 11: 781 – 789.en_US
dc.identifier.citedreferenceKies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010; 28: 8 – 14.en_US
dc.identifier.citedreferenceSchmitz M, Driesch C, Jansen L, Runnebaum IB, Dürst M. Non‐random integration of the HPV genome in cervical cancer. PloS One. 2012; 7: e39632.en_US
dc.identifier.citedreferenceNicolai P, Castelnuovo P. Chapter 49. Benign tumors of the sinonasal tract. In: Flint PW, Haughey BH, Lund VJ, et al., eds. Cummings Otolaryngology–Head Neck Surgery. 5th ed. Philadelphia, PA: Mosby Elsevier; 2010: 717 – 727.en_US
dc.identifier.citedreferenceBarnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002; 15: 279 – 297.en_US
dc.identifier.citedreferencePensak ML. Controversies in Otolaryngology. New York: Thieme; 2001.en_US
dc.identifier.citedreferenceSyrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta‐analysis. Laryngoscope. 2013; 123: 181 – 192.en_US
dc.identifier.citedreferenceLawson W, Schlecht NF, Brandwein‐Gensler M. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008; 2: 49 – 59.en_US
dc.identifier.citedreferenceBeck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE, Bradford CR. Presence of human papillomavirus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg. 1995; 113: 49 – 55.en_US
dc.identifier.citedreferenceKatori H, Nozawa A, Tsukuda M. Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal‐inverted papilloma. Clin Oncol. 2006; 18: 300 – 305.en_US
dc.identifier.citedreferenceBeck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE, Bradford CR. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg. 1995; 113: 558 – 563.en_US
dc.identifier.citedreferenceHarris MO, Beck JC, Lancaster W, Gregoire L, Carey TE, Bradford CR. The HPV 6 E6/E7 transforming genes are expressed in inverted papilloma. Otolaryngol Head Neck Surg. 1998; 118 ( 3 Pt 1 ): 312 – 318.en_US
dc.identifier.citedreferenceZanier K, Boulade‐Ladame C, Rybin V, et al. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self‐association mechanism required for E6‐mediated degradation of p53. Structure. 2012; 20: 604 – 617.en_US
dc.identifier.citedreferenceScheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV‐16 E6 and E6‐AP complex functions as a ubiquitin‐protein ligase in the ubiquitination of p53. Cell. 1993; 75: 495 – 505.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
alr21524.pdf
Size:
269.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.